Highest-paying jobs in Germany: Official data and job postings reveal top salaries
Germany is the world's third-largest economy, with a projected GDP of $4.74 trillion (€4.12tn) in 2025. According to IMF estimates from April of this year, it ranks among the top 20 countries in GDP per capita, with its total standing at $55,911 (€47,206).
Germany is also the top EU destination for immigrants in total — combining arrivals from both within and outside the bloc, according to Eurostat. Some of them are highly skilled and dream of finding good, well-paid jobs.
So, what are the highest-paying positions in Germany, and what are the average annual earnings for these roles?
Euronews Business takes a closer look at the highest salaries in Germany using two sources that reflect different aspects of the job market.
The first is the gross earnings dataset from the Federal Statistical Office (Destatis) from April 2024. While the data is reported monthly, it has been converted into annual figures by multiplying by 12.
Euronews has also looked at job postings from global hiring firm Indeed, covering annual earnings from May 2024 to April 2025.
According to Destatis, aviation is the top-paying sector in Germany, with a median gross annual salary of €336,000. Median earnings in this field typically start from €132,000.
In the healthcare industry, median annual earnings range between €108,000 and €156,000, followed by the legal and judiciary sector, where salaries fall between €84,000 and €144,000.
In academia and research, median salaries range from €72,000 to €120,000, closely followed by the IT and engineering sector, where salaries fall between €72,000 and €114,000. Public sector employees are also well paid, with median salaries ranging from €60,000 to €114,000.
Retail and services represent the lowest-paid sector, with median annual earnings ranging from €30,000 to €42,000.
The average gross monthly earnings in April 2024 were €4,634, amounting to €55,608 annually in Germany.
Pilots have the highest median annual gross earnings in Germany, with salaries varying based on experience and specific roles. Those in highly complex aviation roles earn a median salary of €342,072, and an average of around €337,152.
Flying instructors in complex roles have a median annual salary of €281,592, ranking them second in terms of median earnings. Among the top 50 highest-paying jobs, four additional aviation roles are also featured: air traffic surveillance and control (complex) at €147,996 (5th), airline and aircraft pilots (complex) at €139,524 (6th), aircraft pilots at €122,484 (12th), and technical air traffic control (complex) at €109,188 (20th).
Healthcare occupations dominate the list of highest-paying jobs in Germany, with 11 roles included in the top 50. At the top of the list are managers in human medicine and dentistry, earning a substantial €165,576 annually and ranking third overall.
Among technical roles, highly complex positions in laboratory medicine and radiology follow closely, with median annual salaries of €131,556 and €129,012, respectively.
Medical doctors are also well represented, especially those in surgical specialties, earning €118,668 per year.
General or unspecified medical practitioners in highly complex roles can expect to earn around €100,000 annually.
Managers in legal services and jurisdiction rank fourth overall, with a median annual salary of €149,280. Judges in highly complex roles follow at 38th place, with prosecutors and lawyers in similarly complex roles ranking just behind them, all earning around €95,000 annually.
Not surprisingly, managerial positions across various sectors appear in the top 50 highest-paying jobs. These sectors include universities, technical research, computer science, public administration, IT systems, software development, accounting, business organisation, and media management.
These managers typically earn more than €100,000 annually, with none earning less than €90,000.
Perhaps one of the most surprising entries in the list is the magicians and illusionists sector, ranking eighth overall with annual earnings of €134,316.
National security service employees in highly complex roles also feature in the top 50, with salaries just over €90,000.
Indeed's list of highest-paying occupations also highlights broader salary trends. Corporate tax advisors top the chart with a median annual salary of €145,000 in Germany. Various sales roles come next in the ranking, such as managing directors and heads of sales, with median earnings ranging from €107,500 to €138,243.
A labour law attorney earns €105,000, while general lawyers receive around €93,334.
System Applications Product consultants earn just under €100,000, with senior system engineers following closely at €95,000. Other tech roles, such as IT security specialists and technical SAP consultants, have salaries around €90,000. In the management category, directors also earn approximately €90,000.
There is only one medical profession appearing on the list — dentists — with a median wage of nearly €86,000 because 'physicians and surgeons' is excluded from Indeed's dataset, requiring a separate analysis.
As jobs and skills continue to evolve, the highest-paying roles are expected to shift as well.
'We anticipate that AI/GenAI, green energy, cybersecurity, and biotechnology will produce new top-earning job titles over the next 5–10 years,' Pawel Adrjan, Director of Economic Research at Indeed, told Euronews Business.
He noted that roles like AI ethicist, GenAI engineers, climate data analysts and key sustainability roles are gaining momentum and are likely to enter the upper salary tiers as demand for specialised expertise in these fields increases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Should You Forget Medical Properties Trust and Buy These Unstoppable Dividend Stocks Instead?
Medical Properties Trust has a 7.2% yield and a history of dividend cuts behind it. Other healthcare REITs have high yields and dividends that have withstood adversity much better. Omega Healthcare has a 7.4% yield, and LTC Properties has a 6.5% yield. 10 stocks we like better than Medical Properties Trust › Medical Properties Trust (NYSE: MPW) has a lofty 7.2% yield. That compares to the S&P 500 index's skinny little 1.2% yield, and the average real estate investment trust's (REIT's) yield of around 4.1%. On the surface, it appears to be an obvious choice. But don't jump at the chance to buy Medical Properties Trust just yet. You can get similarly large yields from healthcare REIT peers Omega Healthcare (NYSE: OHI) and LTC Properties (NYSE: LTC), and both offer a more compelling dividend story than Medical Properties. Here's what you need to know. Take a look at the chart below for Medical Properties Trust. The orange line is the quarterly dividend, and the purple line is the stock price. Notice the massive drop in both that has occurred since 2022. That was when some of the REIT's large tenants started to experience financial troubles. It was the start of a tense and complicated period when a small number of Medical Properties Trust's tenants failed, and it had no choice but to cut its dividend. For long-term dividend investors, the lofty 7.2% yield on offer from Medical Properties Trust comes with some lofty risks. It's possible that the bad news is all out, and the REIT can start to turn its business around. However, that's far from a certainty. Unless you're willing to bet that the future will look much brighter from here, most dividend investors will probably want to tread with caution. In fact, even if a turnaround is underway, it's likely to be a years-long process. There's a contrast to be made here with healthcare REITs Omega Healthcare and LTC Properties. Both of these REITs focus on senior housing, including nursing homes and assisted living facilities. During the coronavirus pandemic's height, both of these property types were hard hit. The reason was pretty simple: COVID-19 is particularly deadly for unvaccinated older adults and spreads easily in group settings. Occupancy fell for both REITs, and there was a drought of new customers. Both Omega and LTC also had to deal with tenant problems, as some of their lessees had trouble paying rent. That would seem like a perfect storm that would lead to a dividend cut. Yet neither Omega nor LTC cut their dividends. To be fair, neither of these REITs has increased their dividends in years. But a static dividend is much better than a dividend cut. Right now, Omega's yield is 7.4%, while more diversified LTC Properties has a 6.5% yield. The future is starting to look brighter for each of these healthcare REITs. Omega's adjusted funds from operations (FFO) rose year over year in the first quarter of 2025, and it increased its full-year guidance. LTC Properties, meanwhile, expects 2025's adjusted FFO per share to be flat to slightly higher. However, it's diversifying its business approach to include senior housing operating properties (SHOP). (SHOP assets are owned and operated by the REIT, though it actually hires a third party to handle day-to-day management of the asset.) As it grows, this business should increasingly benefit from the growth in demand for senior housing as the U.S. population ages. The key takeaway here, however, is that, when faced with adversity, Omega and LTC Properties held firm in their commitment to shareholders. They adjusted as needed to keep paying. Medical Properties Trust, on the other hand, couldn't manage that feat. The past doesn't predict the future, of course, but the past is all we have to go on as investors. And since all three of these healthcare REITs have faced material adversity just recently, their strengths and weaknesses have been laid bare. While the worst might be over for Medical Properties Trust, most dividend investors should probably err on the side of caution with either Omega, which has a higher yield, or LTC Properties, which has a lower yield but a far more diversified business model. Before you buy stock in Medical Properties Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medical Properties Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Should You Forget Medical Properties Trust and Buy These Unstoppable Dividend Stocks Instead? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
35 minutes ago
- Yahoo
Meet the nine private humanoid robot firms shaping the future
The humanoid robot arms race is on, and it's not just Tesla Inc (NASDAQ:TSLA) making noise with its Optimus humanoid—the real action is happening among a new generation of private players, each betting big on a future where humanoids are everywhere from factory floors to your living room, according to UBS analysts. "Understanding what these private companies are working on and tracking their progress can help inform investors about the future/feasibility of the humanoid robot opportunity and use cases such as more plant automation,' UBS analysts said in a recent note, pointing to a wave of start-ups already landing deals with auto giants like BMW (ETR:BMWG) and Mercedes. Figure AI, founded in 2022, is going all-in on autonomous humanoids for manufacturing, logistics, and retail. Figure's BotQ facility can crank out up to 12,000 robots a year, and the company is already using its own robots to build more robots. After a $1.5 billion Series C in May 2025, Figure's valuation soared to $39.5 billion, with its first commercial deal inked with BMW and a second, undisclosed 'major US company' already signed. Between these two customers, Figure believes there's a path to 100,000 robots over the next four years. Agility Robotics, meanwhile, is already deploying its Digit robots in logistics and manufacturing, targeting the more than one million unfilled material handling jobs in the U.S. With partnerships ranging from GXO Logistics Inc (NYSE:GXO) and Schaeffler to Tompkins (NYSE:TMP) Solutions, Agility is scaling up quickly, pushing robots-as-a-service deals and using its Agility Arc platform to control robots in tandem with other equipment. The company recently upgraded Digit's battery life and safety features, and a minority investment from Schaeffler signals growing industry confidence. Collaborative Robotics, or Cobot, is taking a different approach, focusing on AI-driven collaborative robots that work shoulder-to-shoulder with people in shared workspaces such as warehouses, hospitals, and factories. Since their 2024 debut, Cobot's Proxie robots have logged over 5,000 operational hours and moved 16,000 carts in customer facilities. The company is developing cobots that integrate large language models, voice recognition, and speech synthesis to enable dynamic, human-like interaction on the job Apptronik, with roots in NASA, has built Apollo, a robot designed for heavy lifting in manufacturing, logistics, and even healthcare. Commercial deployments began with Mercedes-Benz (OTC:MBGAF) in 2024, and new partnerships with Jabil and Google (NASDAQ:GOOGL) DeepMind are helping scale both production and AI capabilities. Apollo is built to perform physically demanding tasks in industrial spaces, working right alongside humans 1X Technologies is targeting the home, planning large-scale deployment of its Neo humanoid in the U.S. in 2025. The company's acquisition of Kind Humanoid is accelerating its tech development, and 1X is backed by EQT (ST:EQTAB) Ventures. Their focus is on creating an abundant supply of labor via safe, intelligent humanoids, scaling from research and development to full-scale manufacturing The next wave of contenders is equally ambitious. Mentee Robotics is building robots that can be 'mentored' in real time by humans, aiming for personalized, adaptive bots. Skild AI is all about general-purpose robotic intelligence, boasting a $4.7 billion valuation and backing from Amazon (NASDAQ:AMZN) and SoftBank (TYO:9984), with its sights set on construction, manufacturing, and security robots. Foundation Robotics Labs is shipping robots for manufacturing, logistics, domestic, and defense use, with a goal of delivering over 10,000 units in 2026. Plus One Robotics, meanwhile, is the parcel-handling specialist, with over one billion picks and AI-powered warehouse automation already saving customers millions in labor costs. While Tesla may be the face of the humanoid-enabled robot future, UBS suggest the real battleground is among these private upstarts—each racing toward a multi-billion-dollar reality, one robot at a time. Related articles Meet the nine private humanoid robot firms shaping the future Tesla plans $8 billion U.S. investment this fiscal year stocks of the week Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Roma could consider Premier League offers for Ndicka
Roma are forced to move on the outgoing market before being able to invest, and the name of Evan Ndicka is back in the news. As reported by Il Messaggero, the Ivorian defender could guarantee a capital gain of close to 40 million euros, essential to settle the accounts in compliance with Financial Fair Play. Advertisement Several Premier League clubs have their eyes on him, including Newcastle and Manchester United, even if the initial intention of the Giallorossi is to keep the prized pieces and sacrifice only secondary elements such as Shomurodov or Paredes. Faced with a concrete offer and budgetary needs, however, the management, now led by Frederic Massara, could also evaluate the possibility of a painful but necessary farewell.
